Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Precigen, Inc. - Common Stock (NQ:PGEN)

1.845 -0.065 (-3.40%)
Streaming Delayed Price Updated: 2:14 PM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Precigen, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Precigen Earnings Perspective: Return On Capital Employed
According to data from Benzinga Pro, during Q2, Precigen's (NASDAQ:PGEN) reported sales totaled $33.58 million. Despite a 11.39% increase in earnings, the company posted a loss of... 
Via Benzinga
Precigen, inc (PGEN) Q2 2021 Earnings Call Transcript
PGEN earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Precigen: Q2 Earnings Insights
Shares of Precigen (NASDAQ:PGEN) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 61.54% year over year to... 
Via Benzinga
Precigen Insights: Return On Capital Employed
During Q1, Precigen (NASDAQ:PGEN) brought in sales totaling $24.51 million. However, earnings decreased 598.82%, resulting in a loss of $17.69 million. Precigen reached earnings... 
Via Benzinga
46 Stocks Moving In Friday's Mid-Day Session
Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67... 
Via Benzinga
Topics Initial Public Offering
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... 
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers GBS (NASDAQ:GBS) stock increased by 41.04% to $5.12 during Friday's pre-market session. Novan (NASDAQ:NOVN) stock increased by 36.5% to $12.34. The company... 
Via Benzinga
The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,... 
Via Benzinga
28 Stocks Moving in Friday's Pre-Market Session
Gainers Amesite Inc. (NASDAQ: AMST) rose 138% to $6.60 in pre-market trading after surging over 25% on Thursday. Chemomab Therapeutics Ltd. (NASDAQ: CMMB) rose 37.5% to $27.50... 
Via Benzinga
Precigen Stock Surges On Positive AG019 Data for Chronic Treatment Of Type 1 Diabetes
Precigen Inc's (NASDAQ: PGEN) subsidiary Precigen ActoBio announced topline results from the Phase 1b/2a study evaluating AG019 ActoBiotics to treat recent-... 
Via Benzinga
The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (... 
Via Benzinga
Precigen: Return On Capital Employed Insights
Precigen (NASDAQ:PGEN) reported Q1 sales of $24.51 million. Earnings fell to a loss of $17.69 million, resulting in a 598.82% decrease from last quarter. In Q4, Precigen earned $3... 
Via Benzinga
Exclusive: Precigen's CEO Breaks Down Biotech's Oncology Platforms, Technology, Differentiators
Cancer treatment has evolved from the use of chemotherapeutic anti-tumor drugs to targeted therapies to monoclonal antibodies to immunotherapies to new, personalized therapeutics... 
Via Benzinga
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.